Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NYXH
#3846
Nyxoah SA Ordinary Shares
3.3
8
USD
+3.36%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.36%
Monthly Change
+7.64%
6 month change
-43.48%
Year Change
-42.42%
Previous Close
3.2
7
Open
3.3
9
Bid
Ask
Low
3.3
8
High
3.3
9
Volume
2
Markets
US Stock Market
Healthcare
NYXH
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
2025
TTM
Cash from operating activities
—
—
—
—
—
—
Cash from investing activities
—
—
—
—
—
—
Cash from financing activities
—
—
—
—
—
—
Free cash flow
—
—
—
—
—
—
News
Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
Nyxoah at Oppenheimer Conference: Strategic U.S. Launch Focus
KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates
Veeva Systems (VEEV) Q4 Earnings and Revenues Surpass Estimates
Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System
Inspire Medical Systems stock soars after Medicare reimbursement boost
Piper Sandler lowers Nyxoah stock price target to $9 from $12
Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates
Nyxoah secures up to $77 million in financing for Genio commercialization